Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
40 Cards in this Set
- Front
- Back
Type 1 INF
|
a. IFNα and INFβ
b. Act as first line of defense against viral antigens c. Production induced by dsRNA |
|
Type 1 INF functions
|
a. Upregulate expression of class I HLA molecules
b. Inhibition of protein translation i. Induces a kinase that phosphorylates and inhibits elongation initiation factor-2 (eIF-2) c. Destruction of viral mRNA i. Induces 2’,5’ oligoadenylate synthetase→ activates latent endonuclease RNAseL |
|
Leukocyte INF/fibroblast INF
|
a. Leukocyte (α)
b. Fibroblast (β) |
|
NK cells
|
a. Recognize virus-infected cells that have down-regulated their display of class I MHC molecules in an attempt to evade Tc cells
b. Use KIRs to survey the surface ofhost cell for MHC molecules d. Recognize MICA and MICB on cell surface e. ADCC |
|
No KIR molecules on host cell
|
i. Host cell is spared from destruction
ii. If viral infection has downregulated Class I MHC, KIRs will not find sufficient ligands and infected cell will be killed |
|
ADCC
|
i. Nk cell recognizes antibody-coated (IgG)targets via CD16 (Fcγ receptor)
|
|
NK cells and INFγ
|
i. INFγ→ type 2, or immune interferon
ii. Weakly antiviral iii. Upregulates MHC molecule expression iv. Stimulates cell-mediated immunity by activating macrophages, Tc cells, and NK cells v. Produces perforin and granzymes |
|
NK cells and FasL
|
i. NK cells use FasL to kill infected or neoplastic host cells
|
|
Complement and virolysis
|
i. Complement can induce virolysis when it binds to the viral envelope
|
|
Components of adaptive immunity effective against viruses
|
a. Adaptive immune response→ 2 weeks
b. T cells and B cells with TCR and sIG molecules specific for virus become activated and undergo clonal expansion in lymph nodes, spleen, and MALT c. Pre-existing circulating antibodies may be able to immediately quell viral infection (2°) |
|
T cell vs. humoral immunity
|
a. T cell immunity is more important than humoral immunity
b. Persons with Ab deficiency seldom suffer from more frequent or more sever viral infections than normal people c. T cell deficiencies result in profound susceptibility to viruses |
|
TH cell responses to viruses
|
a. Tc cells become activated by interacting with the infected cell via TCR/antigen, CD8/class I MHC, CD40/CD40L, CD28/B7 interactions
b. Activation also stimulated by INFγ and IL-2 and type 1 INF c. Kill host cell by perforin, granzymes, granulysin, INFγ, and FasL |
|
Ab-mediated immunity to viruses
|
a. Neutralization of virus infectivity by binding to viral components needed for attachment
b. Inactivation of viral enzymes needed for host cell invasion c. Activation of classical complement→ lysis of virions and infected host cells d. Opsonization of virions for phagocytosis e. Facilitation of ADCC against virus-infected cells |
|
Gram (-)
|
i. Thin peptidoglycan layer
ii. LPS in outer membrane iii. LPS differs among serotypes of bacterial species→ Ab for one serotype ineffective against other serotypes iv. Lipid A moiety→ activates alternative complement, stimulates release of IL-1, IL-6, and TNFα through CD14/TLR4 |
|
Gram (+)
|
i. Thick peptidoglycan layer
ii. C3b/C4b effective as opsonins→ phagocytes iii. Contain lipoteichoic acid in cell walls iv. TLR2/CD14+LTA=release of pro-inflammatory cytokines from phagocyte v. Superantigens produced by gram (+) bacteria participate in gram (+) septic shock |
|
Septic shock
|
i. Can be gram (+) or gram (-)
ii. Implies presence of an infection somewhere in the body iii. Bacteria cannot be recovered from bloodstream iv. 70% of cases due to gram (-) infections |
|
Physical and chemical barriers to bacteria
|
i. Found on skin and mucosal surfaces
ii. Lysozyme enzyme in tears, sweat, and saliva→ breaks down peptidoglycan |
|
Commensal microorganisms (normal flora)
|
i. Prevent colonization by pathogenic species
ii. Prolonged antibiotic usage can dirupt the normal flora and lead ot infection by Candida albicans (yeast) or Clostridium difficile (+) iii. Albicans→ thrush iv. Difficile→ diarrhea or pseudomembranous colitis |
|
Reversal of loss of flora
|
1. Yogurt
2. Sweet acidophilus milk 3. Probiotic tablets with Lactobacillus or Bifidobacterium |
|
Neutrophils and macrophages
|
i. PAMP/TLR interactions
ii. IgG, CRP, complement iii. Phagocytes kill bacteria using lysosomal enzymes or respiratory burst |
|
Lectin and alternative pathways
|
i. Activated by MBL and LPS
ii. Activation causes lysis of gram (-) bacteria and opsonization of (+) and (-) bacteria iii. C5-C9 deficiency→ infection by Neisseria (-) |
|
γδ cells and NKT cells
|
i. Act as sentires to prevent bacterial invasion of epithelial and MALT by recognizing acterial ipid antigens in association with CD1 molecule
|
|
TH cells
|
i. Activated by macrophages/MHC II
ii. Can differentiate into TH1, TH2, TH17 |
|
B cells
|
i. Produces antibodies that:
1. Perform a WIDE VARIETY OF FUNCTIONS |
|
Immune response to fungi
|
a. Cause serious disease only in individuals whose immune systems are compromised by long-term corticosteroid use, congenital or acquired immunodeficiencies, chemotherapy, or immunosuppressive therapy
b. Neutrophils or macrophages with glucan receptors can kill fungi with defensins and ROS |
|
TH1/TH17 and fungi
|
i. Most important subsets in fighting fungi
ii. High correlation between T cell deficiency and enhances susceptibility to infections iii. TH2 responses to fungi detrimental to human host |
|
Immune response to protozoans
|
a. Eliminated by Ab-mediated mechanisms (extracellular)
b. Intracellular protozoa induce TH1-derived cytokines (INFγ) to activate macrophages and Tc cells for elimination of infected host cells |
|
Immune response to helminths
|
a. Typically macrophages and neutrophils
|
|
Frustrated phagocytosis
|
i. Neutrophils
ii. Release hydrolytic enzymes extracellularly iii. Damage worms that are too large to engulf iv. Antigens released by dead or dying worms taken up by macrophages, present antigens to TH2 cells v. TH2→ IL-4/IL-13→ IgE by B cells vi. TH2→ IL-5→ eosinophil recruitment |
|
IgE and helminths
|
i. IgE coats worms and cross-links with high affinity Fce receptors on mast cells and basophils
ii. Cross-linkage leads to degranulation and release of histamine and SRS-A 1. Smooth muscle contraction and increased vascular permeability→ worm expulsion and increased extravasation of eosinophils from bloodstream into tissue |
|
Eosinophil arrival at helminth infection site
|
i. Esoinophilic Fce receptors cross-linked by IgE on worm
ii. Eosinophil degranulates, releases major basic protein and eosinophil cationic protein |
|
Major basic protein
|
a. Damages worm integument
|
|
Eosinophil and ROS
|
1. Eosinophils can produce ROS and NO species
2. Eosinophils inhibit mast cell-derived histamine by producing histaminase 3. Inhibits SRS-A by arylsulfatase 4. Help to eliminate worm and turn off inflammatory reactions |
|
Bacterial capsules
|
i. Antiphagocytic, neutralized by antibody
|
|
Antigenic variation
|
i. Allows microbe to doge the immune system by changing antigens displayed on microbe surface
Shift/drift |
|
Antigenic drift
|
a. Point mutations in viral genome result in minor antigenic changes to viral hemagglutinin and/or neuraminidase molecules over time
|
|
Antigenic shift
|
a. Major, abrupt change in hemagglutinin and/or neuraminidase molecules that results from reassortment of the segmented influenza genome when more than one viral subtype infect the same host cell
|
|
Multiple serotypes
|
i. Infection with one serotype does not confer protection against other serotypes
|
|
Immune suppression
|
i. Epstein-Barr virus encodes a protein similar to IL-109 that interferes with TH1 maturation and function
ii. HIV kills CD4+ cells |
|
Blocking of IgG Fc-mediated effector functions
|
i. Protein A from staphylococci
ii. Protein G from streptococci iii. Bind to Fc fragment of IgG so that IgG cannot fix complement, interfere with opsonization, or facilitate ADCC |